Successful trial results in the next few years could save thousands of lives and generate billions in new annual revenue for ...

Capuchin monkeys in Panama were filmed carrying howler monkey babies, sparking confusion among scientists. The unusual ...

A CRISPR treatment seems to have been effective for a baby’s devastating disease, but it is not clear whether such bespoke therapies can be widely applied ...

The researchers described the unprecedented speed of the oversight steps as being "through alternative procedures." In month ...

Scientists were able to create a bespoke treatment for KJ Muldoon’s rare genetic disorder within six months. It could be a ...

It utilizes HuidaGene’s hfCas12Max, a CRISPR nuclease developed using its ... completed preclinical studies in DMD mice and monkeys. They report that in mice, HG302 restored dystrophin protein ...

The CRISPR technology market is poised for explosive ... as tracked by Insider Monkey’s database of 900 hedge funds at the end of Q3 2024. At Insider Monkey, we are obsessed with the stocks ...

CRISPR Therapeutics AG (NASDAQ ... Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter ...

A Californian firm called Excision BioTherapeutics has previously shown that a CRISPR-based approach can reduce the amount of dormant virus in monkeys infected with a similar virus to HIV.

But results from preclinical studies of a close analogue of EBT-101 that was tested in monkeys are extremely promising, offering hope that CRISPR-Cas9 may be the key to eliminating HIV infections.